Long-Term Debt: The sum of all long term debt fields.
Ascentage Pharma Group International - Unsponsored ADR (AAPG) had Long-Term Debt of $108.28M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$421.01M |
|
$152.76M |
|
$179.98M |
|
$566.78M |
|
$235.00M |
|
|
Long-Term Debt |
$108.28M |
$141.00M |
|
$375.99M |
|
$190.79M |
|
$177.83M |
|
$190.79M |
|
-- |
|
| Cash Flow Statement Financials | |
$-167.90M |
|
$-143.01M |
|
$363.23M |
|
$127.71M |
|
$171.00M |
|
$43.28M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|